News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-22 11:31:9 am Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis GlobeNewsWire
2024-02-14 4:0:0 am Cogent Biosciences Announces Oversubscribed $225 Million Private Placement GlobeNewswire
2024-02-05 6:0:0 am Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting GlobeNewswire
2024-01-09 5:0:0 am Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics GlobeNewswire
2024-01-02 5:0:0 am Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire
2023-12-11 4:55:0 am Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) GlobeNewswire
2023-12-09 10:30:0 am Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM) GlobeNewswire
2023-12-07 6:0:0 am Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer Symposium GlobeNewswire
2023-12-04 5:0:0 am Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual Meeting GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information